Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST): a Randomized Feasibility Trial

Trial Profile

Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST): a Randomized Feasibility Trial

Completed
Phase of Trial: Phase I/II

Latest Information Update: 18 Apr 2016

At a glance

  • Drugs Fibrinogen (Primary)
  • Indications Wounds and injuries
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms FiiRST
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 13 Apr 2016 Status changed from recruiting to completed according to the ClinicalTrials.gov.record
    • 28 Oct 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top